InChI=1S/C25H44NO7P/c1- 2- 3- 4- 5- 6- 7- 8- 9- 10- 11- 12- 13- 14- 15- 16- 17- 18- 19- 25(28) 31- 22- 24(27) 23- 33- 34(29,30) 32- 21- 20- 26/h6- 7,9- 10,12- 13,15- 16,24,27H,2- 5,8,11,14,17- 23,26H2,1H3,(H,29,30) /b7- 6- ,10- 9- ,13- 12- ,16- 15- /t24- /m1/s1 |
ROPRRXYVXLDXQO-XSQXPFHXSA-N |
CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(=O)OC[C@@H](O)COP(O)(=O)OCCN |
|
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via lysophosphatidylethanolamine 20:4 )
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
(via 1-acyl-sn-glycero-3-phosphoethanolamine )
|
|
(2R)- 3- {[(2- aminoethoxy)(hydroxy)phosphoryl]oxy}- 2- hydroxypropyl (5Z,8Z,11Z,14Z)- icosa- 5,8,11,14- tetraenoate
|
(5Z,8Z,11Z,14Z-eicosatetraenoyl)-lysophosphatidylethanolamine
|
HMDB
|
1-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-sn-glycero-3-phosphoethanolamine
|
LIPID MAPS
|
1-arachidonyl-sn-glycero-3-phosphoethanolamine
|
ChEBI
|
1-O-arachidonoyl-sn-glycero-3-phosphoethanolamine
|
ChEBI
|
1-O-arachidonyl-sn-glycero-3-phosphoethanolamine
|
ChEBI
|
LPE(20:4)
|
HMDB
|
LPE(20:4/0:0)
|
HMDB
|
LPE(20:4ω6/0:0)
|
HMDB
|
LysoPE(20:4)
|
HMDB
|
LysoPE(20:4/0:0)
|
HMDB
|
LysoPE(20:4ω6/0:0)
|
HMDB
|
Lysophosphatidylethanolamine(20:4)
|
HMDB
|
Lysophosphatidylethanolamine(20:4/0:0)
|
HMDB
|
PE(20:4(5Z,8Z,11Z,14Z)/0:0)
|
LIPID MAPS
|
PE(20:4/0:0)
|
LIPID MAPS
|